HCP Investments Unloads 7.45% Stake in Ind-Swift Laboratories Over Three-Day Period

HCP Investments Continues to Sell Stake in Ind-Swift Laboratories

On April 20, HCP Investments continued its trend of paring its stake in Ind-Swift Laboratories for the third consecutive session. The company sold eight-tenth of a percent stake in the pharmaceutical firm via open market transactions.

The stock closed with a positive bias on the Bombay Stock Exchange (BSE), where the transaction took place on Monday, rising 0.08 percent to Rs 132.10 amid high volumes. However, the trend was different on the National Stock Exchange (NSE), where the stock soared 5.34 percent to Rs 138.9.

On Monday, HCP Investments sold 7 lakh Ind-Swift Laboratories shares (0.8 percent stake) on the BSE, at Rs 131.14 per share, valued at Rs 9.17 crore. This transaction has resulted in HCP Investments selling 7.45 percent stake in the pharma company in three days against its 8.65 percent shareholding as of February 24, 2026.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Meanwhile, other key market movements were observed. HEG, a graphite electrodes manufacturer, fell 0.58 percent to Rs 629.30 on the NSE. GDN Ventures LLP offloaded 10 lakh shares (0.51 percent stake) in HEG at Rs 631.02 per share, amounting to Rs 63.1 crore.

In other news, Infinity Investors India has acquired 2 lakh shares in Hilltone Software and Gases for Rs 1 crore at Rs 50 per share. Despite this acquisition, the stock was down 1.73 percent to Rs 48.74 on the BSE.